{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:12:04Z","timestamp":1770498724545,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbrc.2009.11.122","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T01:46:26Z","timestamp":1259372786000},"page":"692-697","source":"Crossref","is-referenced-by-count":15,"title":["Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3\u2013NS4A proteins"],"prefix":"10.1016","volume":"391","author":[{"given":"Marie-Jos\u00e9e","family":"Massariol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Thibeault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.11.122_bib1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib2","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.22127","article-title":"Hepatitis C genotype 4: what we know and what we don\u2019t yet know","volume":"47","author":"Kamal","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2009.11.122_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.20819","article-title":"Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes","volume":"42","author":"Simmonds","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib6","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1099\/vir.0.80401-0","article-title":"Genetic diversity and evolution of hepatitis C virus \u2013 15 years on","volume":"85","author":"Simmonds","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib7","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1002\/hep.1840360716","article-title":"Optimal therapy of hepatitis C","volume":"36","author":"Di Bisceglie","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib8","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S1542-3565(05)00711-1","article-title":"Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6","volume":"3","author":"Nguyen","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/595848","article-title":"New therapies for hepatitis C virus infection","volume":"48","author":"Soriano","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2009.11.122_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib11","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.67.5.2832-2843.1993","article-title":"Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites","volume":"67","author":"Grakoui","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0969-2126(00)80025-8","article-title":"Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease\u2013helicase","volume":"7","author":"Yao","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.bbrc.2009.11.122_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0092-8674(00)81351-3","article-title":"Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide","volume":"87","author":"Kim","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2009.11.122_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/bi801931e","article-title":"Use of the fused NS4A peptide\u2013NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3\u2013NS4A","volume":"48","author":"Thibeault","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2009.11.122_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature02099","article-title":"An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus","volume":"426","author":"Lamarre","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2009.11.122_bib16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.08.002","article-title":"Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients","volume":"127","author":"Hinrichsen","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib17","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1128\/JVI.78.14.7352-7359.2004","article-title":"Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061","volume":"78","author":"Thibeault","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib18","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/AAC.00699-08","article-title":"Preclinical characteristics of the hepatitis C virus NS3\/4A protease inhibitor ITMN-191 (R7227)","volume":"52","author":"Seiwert","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2009.11.122_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2009.11.122_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2009.11.122_bib21","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/JCM.43.2.733-739.2005","article-title":"Comparison of hepatitis C virus NS5b and 5\u2032 noncoding gene sequencing methods in a multicenter study","volume":"43","author":"Laperche","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib22","first-page":"201","article-title":"The behavior and significance of slow-binding enzyme inhibitors","volume":"61","author":"Morrison","year":"1988","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib23","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib24","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/JVI.77.7.3950-3961.2003","article-title":"Hepatitis C virus NS3 ATPases\/helicases from different genotypes exhibit variations in enzymatic properties","volume":"77","author":"Lam","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib25","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1053\/j.gastro.2003.09.023","article-title":"Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon","volume":"125","author":"Kato","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2009.11.122_bib26","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1128\/JVI.02088-06","article-title":"The NS3 helicase and NS5B-to-3\u2032X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells","volume":"81","author":"Murayama","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrc.2009.11.122_bib27","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1128\/JVI.00032-07","article-title":"Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras","volume":"81","author":"Binder","year":"2007","journal-title":"J. Virol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09023183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X09023183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T22:51:00Z","timestamp":1590274260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X09023183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0006291X09023183"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.122","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}